Related Experiment Video

Updated: Jul 16, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.2K

Lipid nanoparticle-based COVID-19 vaccines: Ensuring pharmaceutical stability, safety, and efficacy

David F Driscoll1,2

  • 1Stable Solutions LLC, Easton, MA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|September 14, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
lipid nanoparticlesparticle size analysisstability

More Related Videos

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

3.9K
Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
08:54

Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector

Published on: May 30, 2025

717

Related Experiment Videos

Last Updated: Jul 16, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.2K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

3.9K
Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
08:54

Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector

Published on: May 30, 2025

717

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Articles linked to this work by shared authors, journal, and citation graph.

The physiological and pharmaceutical roles of MCTs and other ingredients in intravenous emulsions containing omega-3 enriched fish oil designed to mitigate cytokine release syndrome.

Frontiers in pharmacology·2025

Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment.

Frontiers in pharmacology·2025

Cytokine Release Syndrome Associated With Immune-Modulating Chemotherapy: Potential Mitigating Role of Intravenous Omega-3 Fatty Acid Triglycerides.

Cancer reports (Hoboken, N.J.)·2024

Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms.

Journal of pharmaceutical sciences·2024

Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function.

Critical care explorations·2023

Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023

From protocol to practice: Safety interventions based on real-world implementation of the SQuID protocol.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Association of meds-to-beds delivery with fewer readmissions at an academic medical center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Evaluation of a triage model for pharmacist review of medication histories collected by pharmacy technicians in the emergency department.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Standardizing pharmacist competency in antimicrobial stewardship across diverse hospital settings.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Bridging the continuity: Practice-enhancing publications about the ambulatory care medication-use process in 2025.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Acetazolamide versus metolazone as adjunctive therapy to loop diuretics in hospitalized patients with volume overload: A retrospective cohort study.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson's Disease and Type 2 Diabetes.

Journal of movement disorders·2026

In vitro feasibility studies for clinical microdialysis with lipophilic compounds: A case study with the antifungal posaconazole.

Journal of pharmaceutical sciences·2026

Patient experience data as a methodological and strategic innovation in clinical trial design.

Drug discovery today·2026

Development of discriminatory and biopredictive bicarbonate buffer-based dissolution method to screen delayed release formulations.

Drug development and industrial pharmacy·2026

α/β-Hydrolase domain-containing 6 (ABHD6) accelerates the desensitization and deactivation of TARP γ-2-containing AMPA receptors.

eLife·2026

Probing protein-lipid interactions by hydrogen/deuterium exchange-mass spectrometry: advances, challenges and future directions.

Chemical science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us